The observed phenotypic changes, including reduced proliferation in normal mammary tissues, as evidenced by wholemount and Ki67 analyses (Figure 1), suggested that metformin exerts inhibitory effects that may prevent the unchecked cellular expansion characteristic of early cancer stages. Here, MKI67 is linked to cancer.